← Back to all signals
RESEARCH PAPER ANALYSIS

Pediatric lung ground glass nodules: a real-world, large-scale CT cohort analysis.

AI interpretation is pending for this paper.

Open original publication →
PMID42098619
JournalBMC medical imaging
Publication Date2026-05-07
Ingested2026-08-02 12:07 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Increasing detection of pediatric ground-glass nodules (GGNs) presents a clinical dilemma lacking robust evidence and guidelines. We aimed to evaluate the short-term natural course of incidental pediatric GGNs through real-world observation. METHODS: This retrospective, single-center, real-world study screened children (0-18 years) undergoing low-dose chest CT between January 1, 2010, and December 15, 2025. Patients with GGNs were included, excluding those with malignancy, immune dysfunction, specific infections, mean diameter < 3 mm or > 30 mm, artificial intelligence recognition failure, or poor image quality. Baseline characteristics, clinical presentation, and CT imaging features were collected and analyzed, with subgroup analyses performed. For patients with follow-up CT, nodule evolution was assessed. RESULTS: Among 14,106 children, 901 (6.4%) had GGNs. After exclusions, 602 patients were included, with a median age of 15 (14, 17) years, 58.6% were male. From these patients, 602 most suspicious GGNs were analyzed, comprising 43 (7.1%) mixed GGNs and 559 (92.9%) pure GGNs. Mixed GGNs showed significantly larger size and higher attenuation than pure GGNs (P < 0.01). Children aged > 12 years had GGNs with larger volume and lower attenuation compared to younger children (P < 0.05). Among the follow-up subgroup (n = 78), with a median follow-up period of 268.5 days, 32 GGNs regressed, 45 remained stable, and only 1 increased in size (pathologically confirmed adenocarcinoma in situ). Smaller GGNs at baseline were more likely to regress (P < 0.05). CONCLUSIONS: GGNs are not uncommon in children on chest CT. In our cohort, most GGNs remained stable or regressed over short-term follow-up. These observations suggest a relatively indolent short-term natural course and may support a conservative management strategy for incidentally detected GGNs in children. Given the limited follow-up duration, these findings should be interpreted with caution. Further studies with longer follow-up durations and larger sample sizes are warranted to elucidate the long-term natural course of pediatric GGNs.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Preference of Traditional Chinese Medicine Service Utilization Among Cancer Patients in China: A Discrete Choice Experiment. Integrative cancer therapies 63.4 2 Insights from strengthening perinatal hepatitis b prevention in healthcare facilities in Delta State, Nigeria: A prospective, pilot implementation intervention. Sage open chronic disease 63.4 3 Osteoid Osteoma Mimicking Brachial Plexopathy in a Child. Oman medical journal 60.0 4 The adjunctive use of Bifidobacterium Quadruple Viable Bacteria with interferon in pediatric acute enteritis: inhibition of gut hormones, pain mediators, and systemic inflammation. American journal of translational research 66.0 5 Balloon-Assisted Squid 12 Embolization of a Renal Angiomyolipoma With Imaging Findings Suggestive of Arteriovenous Communication: A Technical Report. Cureus 57.5 6 Advanced Paternal Age: Implications on Fertility, Pregnancy Outcomes, and Offspring Health. The journal of obstetrics and gynaecology research 71.5 7 Long-Term or Recurrent Antibiotic Use During Childhood or Adolescence and the Risk of Kidney Cancer: A Cohort Study. Cancer medicine 64.0 8 Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection. Pediatric gastroenterology, hepatology & nutrition 63.25 9 Integrative network toxicology and transcriptomic analyses identify DCP1B and HAS2 as key prognostic biomarkers in formaldehyde-associated Wilms tumor. The Journal of international medical research 61.05 10 Programmed cell death evasion in BRAF V600E-driven primary CNS tumors and thyroid cancer brain metastases. Frontiers in neurology 56.0 11 Mycosis fungoides in a Mexican pediatric series: Clinical, immunophenotypic, and therapeutic features. Revista medica del Instituto Mexicano del Seguro Social 64.14 12 [Dermatoscopic "sky full of stars" pattern in a congenital melanocytic nevus with follicular distribution]. Revista medica del Instituto Mexicano del Seguro Social 47.5 13 MGA::NUTM1 fusion sarcoma: expanding the spectrum of NUT-rearranged sarcomas with extensive review of the literature. American journal of clinical pathology 69.1 14 Clinical and pathological characteristics of congenital neuroblastoma in 15 Chinese infants: a retrospective analysis from a single-center. Frontiers in medicine 62.6 15 Single-cell transcriptomic analysis reveals fatty acid metabolic heterogeneity and identifies DKK1 as a candidate prognostic factor in osteosarcoma. Frontiers in endocrinology 65.5 16 Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study. Frontiers in pharmacology 72.86 17 Impaired bone health after pediatric acute lymphoblastic leukemia treatment despite normal DXA: insights from high-resolution peripheral quantitative computed tomography. Frontiers in endocrinology 65.84 18 The success-failure inversion in modern medicine. Frontiers in public health 60.5 19 High prevalence of gonadal dysfunction in pediatric sarcoma survivors: insights from hormonal and clinical markers. Frontiers in pediatrics 67.1 20 Rule-derived preoperative inflammatory-lymphocyte recovery phenotype and pathological response in resected osteosarcoma: a retrospective cohort study. Frontiers in immunology 76.62 21 Advances in tumor necrosis factor-α inhibitors for the treatment of juvenile idiopathic arthritis-associated uveitis. Frontiers in immunology 70.2 22 Amphotericin B Colloidal Dispersion Is Effective and Safe for the Treatment of Invasive Aspergillosis in Chinese Patients with Hematologic Disease: A Multicenter, Prospective, Observational, Real-World Study. Drug design, development and therapy 73.34 23 Time of diagnosis of congenital upper limb anomalies: a cohort study of 703 patients from a local registry in Norway. Acta orthopaedica 63.5 24 Health risk assessment of radon concentrations and water quality parameters in drinking well water of Erbil villages. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 58.7 25 Manufacturing cost analysis and exploratory economic evaluation of natural killer cell immunotherapy for paediatric solid tumors. Clinical & translational immunology 68.52 26 Large Undifferentiated Sarcoma of the Liver: A Rare Case Report and Literature Review. Clinical case reports 47.4 27 Beyond Immediate Release: FDM-Printed Pediatric 6-Mercaptopurine Chewable Tablets with Spontaneous In Situ Nanostructure Formation. AAPS PharmSciTech 63.4 28 Children's participation in assent to paediatric oncology research: experiences of children, siblings and parents. Trials 58.5 29 Single and multiple oral giant cell fibromas: a case report and review of the literature. Journal of medical case reports 53.0 30 Heavy Metal Concentrations and Health Risk Assessment of Melon Seeds (Citrullus lanatus) From Selected Markets in Ghana. International journal of food science 56.0 31 Role-play in graduate genetic counseling education: a practicum experience in South Korea. Ewha medical journal 56.0 32 Family-centred psycho-oncological counselling for parents with cancer: a longitudinal secondary data analysis of psychological distress, family functioning and parental concerns. BMC cancer 59.5
PATIENT-FRIENDLY SUMMARY

Pediatric lung ground glass nodules: a real-world, large-scale CT cohort analysis.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic